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Abstract 
The practice of Orthokeratology has been around since the invention of contact lenses. As techniques in 
manufacturing contacts have evolved, so have the results obtainable in Orthokeratology. The newer 
"reverse geometry" lenses have allowed practitioners to produce dramatic alterations in corneal curvature 
in a short period of time. This study was a prospective, multi-center, open-label, non-randomized study to 
determine the safety; efficacy and acceptability of a new reverse geometry lens design. Traditional 
orthokeratology lens designs have relied on spherical radii in the lens periphery to create the desired 
flattening effect. The study design incorporates a series of aspheric curves in the lens mid-periphery to 
permit better lens alignment with the aspheric peripheral cornea. All lenses will be manufactured in a FDA 
approved RGP lens material, Paflufocon B. The study will enroll 14 patients, all who are currently 
optometry students. Subjects must meet the eligibility as outlined in the investigational protocol. All 
patients will be fitted with the new lens design that is flatter centrally and steeper in the periphery. 
Scheduled follow-up examinations will be conducted at two weeks, one, two, and three months. after 
dispensing. Additional visits will be conducted at eight, twenty-four, forty-eight, and seventy-two hours 
after the three-month visit to determine the half-life of the unaided visual acuity improvement. It is 
hypothesized that the lenses are safe and effective and accepted by the usual population to be treated, 
for the reduction of the magnitude of naturally occurring myopia with refractive astigmatism when used 
according to the protocol of the study. 
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Abstract 
The practice of Orthokeratology has been around since the invention of contact lenses. As 
techniques in manufacturing contacts have evolved, so have the results obtainable in 
Orthokeratology. The newer "reverse geometry" lenses have allowed practitioners to 
produce dramatic alterations in corneal curvature in a short period of time. This study 
was a prospective, multi-center, open-label, non-randomized study to determine the safety; 
efficacy and acceptability of a new reverse geometry lens design. Traditional 
orthokeratology lens designs have relied on spherical radii in the lens periphery to create 
the desired flattening effect. The study design incorporates a series of aspheric curves in 
the lens mid-periphery to permit better lens alignment with the aspheric peripheral cornea. 
All lenses will be manufactured in a FDA approved RGP lens material, Paflufocon B. The 
study will enroll 14 patients, all who are currently optometry students. Subjects must meet 
the eligibility as outlined in the investigational protocol. All patients will be fitted with the 
new lens design that is flatter centrally and steeper in the periphery. 
Scheduled follow-up examinations will be conducted at two weeks, one, two, and three 
months. after dispensing. Additional visits will be conducted at eight, twenty-four, forty-
eight, and seventy-two hours after the three-month visit to determine the half-life of the 
unaided visual acuity improvement. 
It is hypothesized that the lenses are safe and effective and accepted by the usual 
population to be treated, for the reduction of the magnitude of naturally occurring myopia 
with refractive astigmatism when used according to the protocol of the study. 
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Introduction 
Reverse geometry lenses were first reported in the literature over ten years ago. The 
purpose of the design was lens centration and surface area equivalence while providing a 
central radius of curvature that was longer than the keratometric measured radius of the 
patient's cornea. Reverse geometry lenses were observed to provide better centration 
than conventional designs in cases of low corneal eccentricity and in cases where greater 
amounts of myopia were targeted for reduction. 
The main objective of this study is to confirm the safety and effectiveness of the use of 
reverse geometry lenses in Paflufocon B material to treat myopia with refractive 
astigmatism. The purpose of the study is to determine the patient acceptance of the 
therapeutic procedure. 
Methods 
Subjects were included based on the following criteria: 
1. Patients may be male or female, of any race, and at least 12 years old at 
the time of the pre-treatment exam. 
2. The prospective eye(s) must have naturally occurring refractive myopia from 
~.50 to -6.00 diopters sphere (spectacle plane), with up to -1.50 diopters 
of refractive astigmatism, as determined by manifest refraction. Patients 
must have spectacle corrected visual acuity of at least 0.04 logMAR in 
each eye. 
3. The prospective eye(s) must demonstrate refractive stability, confirmed by 
clinical records. Neither their spherical nor the cylindrical portion of the 
manifest refraction may have changed more than 0.50 diopters during the 
twelve month period immediately preceding the baseline examination. The 
astigmatic axis may not vary by more than 15 degrees. 
4. If the patient wears rigid contact lenses in the prospective eye(s), lens use 
must cease at least four weeks prior to the pre-treatment exam. The 
subject must have two central keratometry readings taken that are at least 
one week apart. The two readings shall not differ by more than 0.50 
diopters in either meridian. The mires should be regular. 
5. Patients must be willing and capable to return for all scheduled follow-up 
visits for a period of at least three months. 
Exclusion Criteria 
1. Female patients who are pregnant, breast-feeding or intend to become 
pregnant over the course of the study. 
2. Patients with a history of any of the following medical conditions: collagen 
vascular disease, autoimmune disease, immunodeficiency diseases, ocular 
herpes zoster or simplex, endocrine disorders (including, but not limited to 
active thyroid disorders and diabetes), lupus, and rheumatoid arthritis. 
3. Patients with a history of intraocular or corneal surgery (including cataract 
extraction), active ophthalmic disease or abnormality (including, but not 
limited to, blepharitis, recurrent corneal erosion, dry eye syndrome, 
neovascularization > 1 mm from limbus), clinically significant lens opacity, 
clinical evidence of trauma (including scarring), or with evidence of 
glaucom~ or propensity for narrow angle glaucoma as determined by 
gonioscopic examination in either eye. This includes any patient with open 
angle glaucoma, regardless of medication regimen or control. Additionally, 
any patient with an IOP greater than 21 mm Hg at baseline is specifically 
excluded from eligibility. 
4. Patients with evidence of keratoconus, corneal irregularity, or abnormal 
video keratography in either eye. 
5. Patients with pupil size greater than 5.5mm in photopic illumination as 
measured with infrared pupilometry; pupil detection component of computer 
assisted video keratography, or slit lamp reticule. 
6. Patients who are participating in any other clinical trial (FDA or other). 
Subject Withdraw! 
Study subjects were told that they were free to withdraw from the study at 
anytime without any penalties. Subjects who move away form the study 
and are unable to return for follow-up will be considered withdrawn from 
the study. If a subject does not return for two consecutive follow-up visits 
after 1 month following treatment, and phone calls and written 
correspondence from the investigator to the subject does not elicit a 
response, the subject will be considered voluntarily withdrawn from the 
study. 
Data Collection 
All clinical data relevant to the conduct and results of this study shall be 
collected for the purpose of analysis. The data collected for the purpose 
of the study shall be made available to the sponsor and FDA for 
comparison to the medical records to assure completeness and accuracy of 
the data. 
Pre-Treatment Exam 
The pre-treatment exam must be performed no more than thirty days 
before the date of dispensing. In the case of patients wearing rigid contact 
lenses, lens wear must cease at least four weeks prior to the pre-treatment 
exam. 
Refraction: 
Distance uncorrected logMar VA 
Manifest Refraction 
Best Corrected logMar VA 
Pupil Size 
Corneal Shape Evaluation 
Manual Keratometry 
Corneal Videokeratography 
Ocular Examination 
Applanation Tonometry 
Anterior Segment Examination 
Lid Position 
Horizontal Visible Iris Diameter 
Dilated Fundus Exam if not conducted within nine months of pre-
treatment 
Psychometric Evaluation 
Qjagnostic lens Evaluation 
Lens Dispensing 
Follow-up Visits 
The following data shall be assessed and recorded for the treated eyes 
after lenses have been dispensed and equilibrated for fifteen minutes. 
Refraction and visual performance 
Manifest Sphero-cylinder Over Refraction 
Best Corrected VA 
Lens-Cornea Relationship 
Central Zone 
Paracentral Zone 
Peripheral Zone 
Lens Dynamics 
Centration 
Movement 
Lens Comfort 
Wearing Regimen 
Assessment of Adverse Events and/or complications 
The following data shall be assessed and recorded for the treated eyes 
during scheduled periodic examinations at two weeks, 1, 2, and 3 months: 
Wearing schedule 
Over Refraction and Visual Performance 
Lens-Cornea Relationship 
Lens Dynamics 
Lens Comfort 
Removal of Lenses: Refraction and Visual Performance 
Corneal Shape Evaluation 
Ocular Examination 
Psychometric Evaluation 
Assessment of Adverse Events and/or complications 
The following data shall be assessed and recorded for a single treated eye 
during scheduled examinations 8, 24, 48 and 72 hours after the three 
month follow up visit: 
Refraction and Visual performance 
Corneal Shape Evaluation 
Ocular Examination 
Psychometric Evaluation 
Assessment of Adverse Events and/or complications 
Results 
Of the 14 subjects enrolled in the study, a total of five subjects completed up to the one 
month follow-up visit. Although the study was intended to progress through a three month 
course, the restrictions imposed by the college schedule restricted the results of this study 
to a one month period. At the baseline visit (see table 1 below), the mean unaided 
acuity of the subjects was measured using the Logmar system and a mean acuity of the 
five subjects was found to be 20/122 in the right eye and 20/129 in the left eye at a 
calibrated distance of 14 feet. The mean subjective refraction using a spherical equivalent 
was -2.08 diopters in the right eye and -2.28 diopters in the left eye. The mean 
photopic pupil size was 4.4 mm in both eyes. The corneal shape as determined by the 
corneal topographer was 0.25 in the right eye, and 0.24 in the left eye. Other data 
obtained at the baseline visit is not presented in this document. 
Table 1. Baseline Data 
No. Unaided VA Subjective Refraction Pupil Size Corneal Shape 
Factor 
OD OS OD OS OD OS OD OS 
1 
20/60 20/80 -1.00-0.25X165 BK -1.50-0.25X105 5.5 5.5 0.42 0.33 
2 20/100 20/125 -2.75 -2. 75-0.50X020 3.0 3.0 0.30 0.30 AP 
3 20/50 20/40 -1.50 -1.50 5.0 5.0 0.07 0.06 SS 
4 20/200 20/200 -2.50 -2.75 4.5 4.5 0.19 0.21 AH 
5 20/200 20/200 -2.50 -2.25-0.50X180 4.0 4.0 0.27 0.29 CB 
AV 20/122 20/129 -2.08* -2.28* 4.4 4.4 0.25 0.24 G 
* These means were calculated using a spherical equivalent value. 
At the one month follow-up visit (see table 2), the hours of wear time were recorded and 
the mean time was 9 hours of wearing time per day. The mean unaided visual acuity 
was again measured using the Logmar method. The mean visual acuities were 20/17.9 in 
the right eye and 20/18.7 in the left eye (see graph 1). A subjective refraction was 
performed for each eye and the mean spherical refractions were --0.25 diopters in the 
right eye and --0.25 in the left eye. Patient reports of comfort were recorded at the one 
month visit. The most common complaints were itching I burning in 2/5 subjects, dryness 
I srcatchiness in 2/5 subjects, and one patient reported significant glare problems. The 
adverse reactions observed included two patients with mild tarsal abnormalities, and two 
patients with mild corneal staining. 
Table 2. 1 Month Data 
No. Avg. Lens Unaided VA Subj. Refraction Comfort 
Wear I Day 
OD OS OD OS (Hr.) 
1 11 20/20 20/20 +0.25 Plano G,18 BK 
2 10 20/12.5 20/12.5 Plano Plano DS AP 
3 7 20/16 20/16 -0.25 Plano SS none 
4 7 20/25 20/25 -0.50 -0.75 DA AH 
5 10 2011-6 2.0/20 -0.-75- -0.50 18, OS ca ,.._ ,_ ,_ 
AVG 9 20/17.9 20/18.7 -0.25 -0.25 
G= glare IB= itching/ burning DS= dryness/ scratchiness DA= discomfort/ awareness 
S= staining MTA= mild tarsal abnormality 
Complications 
S,MTA 
MTA 
none 
s 
none 
Graph I. Pre- vs. Post-Ortho K Average Uncorrected Visual Acuities 
OD OS OD OS 
Pre-Ortho K Post-Ortho K 
Discussion 
The art and science of orthokeratology has been under investigation for some time. There 
are skeptics who do not believe that this method of myopia reduction will become a 
popular method used by eye care practitioners. However, there is no doubt from our 
results, and the results of others, that ortho-k can be effective way to reduce myopia in 
select candidates. It has been illustrated by this study that the selection of patients is 
crucial to the success of the patient with this method of myopia correction. The study to 
one month was completed for 5 of the 14 patients who enrolled originally. Motivation, 
desired goals, and commitment to the lens wearing schedule are important when selecting 
and explaining to candidates what is required if success is to be likely. In addition, 
previous RGP wear presented as an aid to the adaptation period in wearing these rigid 
lenses, and did not seem to have a significant impact on the end results. The results 
can be projected to produce some promising future uses of this lens material for the 
purposes of ortho-k. 
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INFORMED CONSENT 
DOCUMENT 
Study 
Paflufocon B in Reverse Geometry Design for Daily Wear for 
Myopia and Myopia With Astigmatism 
Institution: 
A. Title Paflufocon B in Reverse Geometry Design 
for Daily Wear for Myopia and Myopia With 
Astiomatism. 
B. Principal Investigator Dr. Roxanne A. Achong 
(503)359-2823 office 
(503)297-5775 home 
C. Location Pacific University College of Optometry 
2043 College Way, UC 692 
Forest Grove, Oregon 97116 
{503) 359-2202 
D. Dates of project: November 1998 - November 1999 
1. Description of Project 
The technique of orthokeratology can be defined as the reduction or 
modification of refractive errors by the programmed applic~tion of 
contact lenses. The technique is accomplished through a single or 
series of progressively flattening lenses which flatten the central 
anterior corneal radius, reducing myopia and myopic astigmatism, 
thereby improving unaided visual acuity. 
You are invited to participate in a six month study to determine the 
safety, efficacy and acceptability of a new contact lens design for 
orthokeratology. Traditional orthokeratology lens designs have relied 
on spherical radii in the lens periphery to create the desired flattening 
effect. The design in this study incorporates a series aspheric curves 
in the lens mid-periphery to permit better lens alignment with the 
aspheric peripheral cornea. 
All lenses will be manufactured in a FDA approved RGP lens material , 
Pafulfocon B. Each patient will undergo a comprehensive eye exam 
to determine eligibility. Subjects must meet the eligibility as described 
in the lnvestigational Protocol. 
If you meet the inclusion criteria you will be fitted with the new RGP 
lens design and placed on a daily wearing schedule. The central 
portion of the lens will be fitted flatter than the central radius of 
curvature of the cornea. This will flatten the central cornea thereby 
temporally correcting your myopia (nearsidedness). 
Scheduled follow-up examinations will be conducted at two weeks, 1, 
2, and 3 months after dispensing. Additional visits will be conducted 
at 8, 24, 48, and 72 hours after the 3 month visit to determine the half 
life of the unaided visual acuity improvement. 
2. Description of Risks: 
All procedures performed in this study will be current, accepted 
clinical procedures for the fitting and management of contact lens for 
orthokeratology. Small amounts of ocular redness and lens 
awareness may occur with lens wear, and there is an extremely small 
risk of ocular infection and/or loss of vision with the use of daily wear 
contact lenses. This risk increases with non-compliance to care and 
follow-up schedules. Subjects who do not comply with prescribed 
regimens will be discontinued from the study and will be required to 
forfeit their lenses. All subjects will sign the informed consent 
document. · 
3. Description of Benefits: 
Subjects accepted for study participation will be supplied with state of 
the art product representing the newest technologies in 
orthokeratology contact lens. Throughout the duration of the 
study, lenses and care solutions and professional fitting fees will be 
complimentary. 
4. Alternatives Advantageous to Subjects: 
Some subjects may be better suited to other types of contact lens 
wear or spectacles. The investigator will endeavor to provide subjects 
unsuited to the study protocol with a prescription for their optimum 
form of vision correction. 
5. Confidentiality of Records: 
.. 
Records of this project will be maintained in a confidential manner and 
no name-identifiable information will be released. 
6. Compensation and Medical Care: 
If you are injured in this study, it is possible that you will not receive 
compensation or medical care from Pacific University, the 
investigators, or any organization associated with the project. 
However, all responsible care will be used to prevent injury .. 
7. Offer to Answer Any Inquiries: 
The investigators will be happy to answer any questions you may 
have at any time during the study. If you are not satisfied with the 
answers you receive, please call Dr. Jennifer Smythe (503) 359-2770 
8. Freedom to Withdraw: 
You are free to withdraw your consent and to discontinue participation 
in this project at any time without prejudice to you. 
I have read the above and understand its meaning. I am 18 years of 
age or over, or this form is signed for me by my parent or guardian. 
Printed Name: 
Signed: _____________ Date: _____ _ 
Address: ______________ Phone: _____ _ 
City: __________ State: ___ Zip: ___ _ 
Name and address of a person not living with you who will always 
know your address: 
Name: 
Address: 
PATIENT COPY 
... · 
PACIFIC UNIVERSITY FAMILY VISION CENTER STUDY 
POLICIES: 
Subjects accepted for participation in this study will receive 
complimentary contact lenses, lens care products and professional 
fitting services throughout the duration of the study. If you prefer to 
transfer your care to a different practitioner, we will be happy to 
forward our data concerning the study upon your written request. 
Subjects not able to successfully complete the study will be given a 
the opportunity to be fitted with an alternate type of contact lens or 
glasses at standard clinic fees. 
NOTE: Subjects who chose to continue in another type of contact 
lens will not receive a refund of the annual care agreement fee; 
however, their services will be covered until their agreement expires. 
During your participation in this project, you are not a Pacific 
University clinic patient for contact lens care. All questions should be 
addressed to the study investigators, who will be solely responsible 
for any treatment (except for an emergency). It is imperative that you 
keep your scheduled appointments to ensure continuity of care and 
data collection by each investigator. 
I UNDERSTAND AND AGREE TO THE POLICIES FOR 
PARTICIPATION IN THIS CONTACT LENS RESEARCH PROJECT 
AT THE PACIFIC UNIVERSITY COLLEGE OF OPTOMETRY 
Name: 
Signature: ---------------------
Date: 
PATIENT COPY 
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p PARAGON VISION SCIENCES 
EVALUATION OF THE SAFETY AND EFFECTIVENESS OF LENSES MADE IN PAFLUFOCON B MATERIAL IN 
REVERSE GEOMETRY DESIGN FOR MYOPIA AND MYOPIA WITH ASTIGMATISM 
GENERAL INFORMATION STUDY: PVS 98 - 2 
IN'fRODUCTION: PARAGON Y,:ision Sciences is evaluating a new lens design for rigid gas permeable contact lenses. 
pARAGON Vision Sciences believes the new design will be safe and effective for the reduction of naturally occurring myopia 
and myopia with astigmatism with resultant improvement in uncorrected distance visual acuity. 
THE LENS: The study lenses are manufactured from Paflufocon B, a rigid lens plastic that has been found to be safe as a lens 
material. Thousands of people are now wearing lenses made from this material. The Paflufocon B lenses in reverse geometry 
design are currently available ONLY from qualified clinical investigators and will be dispensed for the sole purpose of 
conducting this study. 
PROCEDURES: As a study volunteer you will first be examined by your doctor to determine your eligibility and lens 
prescription. If you are eligible, you will receive a pair of study lenses and will be instructed to wear these study lenses during 
waking hours for prescribed periods up to 16 hours per day. During the ~tudy you will attend a minimum of five office visits: 
Initial, 2 Week, 1 month, 2 month and 3 month. F.ach visit should requir'e 30-45 minutes. During each visit you will receive 
an eye examination. You will be issued and instructed to use a currently marketed, FDA approved cleaning and disinfecting 
regimen. At the end of the study, at your practitioner's discretion, yoU will be allowed to keep the test pair of study lenses. 
BENEl'TI'S: The study lenses have been designed to provide excellent visual acuity and oxygen transmission to the eye The 
lens design is believed to provide a reduction in the refractive error of a treated eye with a resultant improvement in the unaided 
vision. This change is believed to be completely reversible and temporary in nature. 
RISKS: No harmful health risks to your eyes are anticipated from using the lenses. As with any contact lens, there are 
potential risks of irritation to the eye and corneal ulcers. Transient distorted vision may occur after removal of the lenses that is 
not corrected with spectacle lenses. No harmful effects are expected from any of the examination procedures used in the study. 
ALTERNATIVES: Currently available alternatives to the study lenses are spectacles or other types of soft, conventional hard 
er rigid gas permeable contact lenses or surgical vision correction. Your eye care professional can discuss these alternatives. 
PARTICIPATION: Your participation in this study is voluntary, and you may refuse to participate without prejudice to your 
care. You are also free to withdraw your consent and to discontinue your participation in this study at any time without 
prejudice to your care. If you miss a study visit or move out of the area, you will be discontinued from the study and you must 
return your lenses. A total of 75 subjects will be enrolled in the study. 
CONFIDENTIALITY: The information collected during this study will be submitted to the sponsor, PARAGON Vision 
Sciences. The U.S. Food and Drug Administration and PARAGON Vision Sciences may review any of your records that 
pertain to this study. The information collected in this study will remain confidential. Your permission for the review of 
confidential information by PARAGON Vision Sciences and the U.S. Food and Drug Administration is granted by signing this 
document. 
MEDICAL TREATMENT: Reasonable medical treatment will be available for any subject incurring physical injuries 
reasonably related to this clinical investigation. For further information, contact William Meyers, Vice President, Science and 
Technology, PARAGON Vision Sciences, 947 F.ast Impala Ave., Mesa AZ 85204. 
QUESTIONS: Your doctor will answer any questions you might have regarding this study. Your doctor is a qualified clinical 
investigator and has been provided with full background information. If a question comes up that your doctor cannot answer, 
he/she can obtain the information from PARAGON Vision Sciences. 
STATEMENT OF INFORMED CONSENT 
I have read all of the above information regarding trial lenses. I understand what I have read and the circumstances have been 
explained to me by my eye care professional. 
I wish to participate in this study under the conditions explained to me and described above. 
Subject Signature: ________________ _ 
Subject Name (Print): _______________ _ Doctor Name: ___________ _ 
Witness: ___________________ _ Date: ___________ _ 
Office Phone No.: Emergency Phone No.: ___________ _ 
If subject is a minor, parental or guardian signature and relationship to subject are required: 
Parent or Guardian Signature: ______________ Relationship to Subject ________ _ 
EXPERIMENTAL SUBJECT'S 
··· BILL OF RIGHTS 
California law states that persons who participate in a medical experiment are 
entitled to certain rights. These rights include but are not limited to: 
• be informed of the nature and purpose of the experiment; 
• be given an explanation of the procedures to be followed in the medical 
experiment, and of any drug or device to be utilized; 
• be given a description of any attendant discoryiforts and risks reasonably to 
be expected from your participation in the ~xperiment; 
• be given an explanation of any benefits to the subject reasonably to be 
expected from participation in the experiment; 
• be given a disclosure of any appropriate alternatives, procedures, drugs or 
devices that might be advantageous to you, and their relative risks and 
benefits; . 
• be informed of the avenues of medical treatment, if any, available to you after 
the experimental procedure, if complications should arise; 
• be given an opportunity to ask questions concerning the experiment or the 
procedures involved; 
• be instructed that consent to participate in the experimental procedure may 
be withdrawn at any time and that you may discontinue participation with 
prejudice; 
• be given a copy of the signed and dated consent form; and 
• be given the opportunity to decide to consent or not to consent to a medical 
experiment without the intervention of any element of force, fraud, deceit, 
duress, coercion or undue influence on your decision. 
\ 
CONFIDENTIAL 
APPENDIX D: CASE REPORT FORMS 
.. 
PSYCHOMETRIC QUESTIONNAIRES 
OKDW-98-2 
16 
10/5/98 
I 
I 
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CASE REPORT FORM 
51UDY ID: PVS 98 - 2 
usE BLACK INK ONL y 
.. 
PARAGON VISION 
SCIENCES 
BASELINE VISIT 
PAGE 1OF3 
1nvestigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: Age: Gender: (circle) 
M F 
Cm1Ii:i::::::mmm@:m11.m1111:;11~:::1u.:s.ura1:::11u.11:11-1tm11111t111s.a111M:1.::1mmm1Im1.i.:'t&m:fi.i.tmi: Informed Consent Complete? (Circle) YES NO 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Leners @ ft. 
(Record test distance in feet from patient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Leners @ ft. Single Letter VA with Subjective Refraction Leners @ ft. 
(Record test distance in feet from patient) 
Horiwntal Vertical 4. Keratometry Horiwntal Vertical 
@ @ 
5. HVID 
mm. mm. 
Upper Lower 6. Position of Lids Upper Lower 
+I - mm +I- mm ( From limbus - Algebraic in mm ) +I- mm +/- mm 
Photopic 7. Pupilometry Photopic 
mm mm 
8. IOP 
mm./hg mm. /hg 
~rnm@::tmm::~1l:::1111:1r::11&s1111®.11111a1ea1:r.1mtcnJ1t1n1u.m1~11•:1 .. 1{"4Q1::1.mm1m1rtl&1r11 
OD 1. Instrument Used: OS 
2. e Value or Shape Factor 
Circle measure reported 
1;11;;;,:mm:~;::::::11lt.mm:~::::::::f1m1I::MiMl1:::~~&t:::::~a1amr1.-.1@e1tw.1111:B.1t1111111mw.trnm~mtrn1mMMi.:::mm;:rtdi.Mt.rnitmmf:f:l1l*~ 
OD (circle uade) OS 
O 1 2 3 4 1. Edema 0 1 2 3 4 
0 1 2 3 4 2. Neovascularization 0 1 2 3 4 
0 1 2 3 4 3. Stainiru! 0 1 2 3 4 
0 1 2 3 4 4. Iniection 0 1 2 3 4 
0 1 2 3 4 S. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
Exnlain: Exnlain: 
Describe any SLE findings Grade 2 or greater: 
CASE REPORT FORM 
STUDY ID: PVS 98 • 2 
USE BLACK INK ONLY 
Investigator N aine: 
Subject Naine: 
PARAGON VISION 
SCIENCES 
Investigator No. : 
BASELINE VISIT 
PAGE 2 OF 3 
Date of Visit: 
Subject No. : 
:m1mmm1mmrnt~ii1M:1::1::r::tm1:11::t::::i::u;1:::::::::::::i::a11•:::w.u:t:SJB.ifi:a111no.m1:::mns.1::u~@timmi:::i1mi::mr.rnrnmimmmim;,1t::mtt:::: 
D I mm Lens Power I Base Curve D I mm 
mm. I mm Total Diameter/ Optic Zone mm. I mm 
mm. I mm Secondary Curve RadidS I Width mm. I mm 
mm. I mm Intermediate Curve Radius I Width mm. I mm 
mm. I mm Peripheral Curve Radius I Width mm. I mm 
mm Center Thickness mm 
Lil!ht Medium Heavy Blend Lil!ht Medium Heavv 
imii'IDltlll,mlRmltlilG.lmmllltU.l.Nlt.lllfi.Bllf:YlJ.ffilll=e.&QJWIB.l&EtlliS.iii!&!Ml8.Qm&Sfi'tt 
OD OS 
Excellent Good Poor 
5 4 3 2 1 
Sphere 
x 
y 
Cylinder 
Letters @ 
x 
ft. 
1. Lens Comfort: 
2. SCOR 
3. LogMar High Contrast Acuity 
Single Letter VA with SCOR I test distance 
4. Lens Centration: 
(In straight ahead gaze, 0.5 mm steps) 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
Letters @ ft. 
x 
y 
0.25 0.5 0.75 1.0 1.25 1.5 5. Lens Movement: 0.25 0.5 0.75 1.0 1.25 1.5 
1.75 2.0 2.25 2.5 >2.5 mm (After normal blink in primary gaze) 1.75 2.0 2.25 2.5 >2.5 mm 
Bearing Aligned Vaulting 6. Lens/Eye Relationship: Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 Optic Zone 1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 7. Lens/Eye Relationship: Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 Reverse Zone 1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 8. Lens/Eye Relationship: Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 Peripheral Zone 1 2 3 4 5 6 7 8 9 10 
::::m@Ml!IlH!lst\Jli:::mJM111:::1~1RIUl!&XllilltlliUllldmili&fitliiifl!witfiiHil&tmi&lM:::M!@@1@:, 
OD Describe any findings outside nonnal OS 
limits 
1. Crvstalline Lens 
2. Pre Retinal Media 
3. Central Retina 
4. Peripheral Retina 
5. Optic Nerve 
6. Other 
Comments on Baseline Exainination: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
USE BLACK INK ONLY 
PARAGON VISION 
SCIENCES 
BASELINE VISIT 
PAGE30F3 
~iw::::::;::~m::::::tIIltltI:@m:::tii:!llI!:IlillI!ldf=~:MHi::;::::i:::1sta111G1n•1101n11m1:1~]Ii~JMW@j@~llN~lliffal@H!IMIMMI@P.MHl:mmrnm1:1l 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: 
(J Reverse Geometry not indicated Q Poor lens centration 
. 
I 
I 
.. -
Subject No.: 
(J Lack of Comfort Q Other:-----------------
(J Lack of Interest 
t.&Immmr;::1:@:ma•11•tKli.iti.flni~:;s.•-l'llr ............. m,1W11&&wmm@1n::::r1M 
D I 
mm. I 
mm. I 
mm. I 
mm. I 
Lil!ht Medium 
Investigator Signature: 
Target Post Treatment Spherical 
Diopters Equivalent (Spectacle Plane) Diopters 
mm Lens Power I Base Curve 
mm Total Diameter/ Optic Zone 
mm Secondary Curve Radius I Width 
mm Intermediate Curve Radius I Width 
mm Peripheral Curve Radius I Width 
mm Center Thickness 
Heavv Blend 
Base Curve 
mm (assuming + 1.00 Diopter Lens Power 
to achieve Target Post Treatment 
Refractive Error) 
Date: 
D I mm 
mm. I mm 
mm. I mm 
mm. I mm 
mm. I mm 
mm 
Lil!ht Medium Heavv 
mm 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
USE BLACK INK ONL y " 
Investigator Name: 
Subject Name: 
PARAGON. VISION 
SCIENCES 
Investigator No.: 
DISPENSING VISIT 1 
PAGE 1OF1 
Date of Visit: 
Subject No.: 
OD: Power: _____ Base Curve: _____ OS: Power: _____ Base Curve: ____ _ 
11mnm::mmmt.Ei!:M1m:mammtrn@M11s.1au0::11eu.QIB.1&.D.M1w1nt.:]1111-w:11NSm:11mm;mmmmmf.f:t.:1mn11rn1m:::::rn:m:r 
OD OS 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
y 
Leners @ 
1. Lens Comfort: Excellent Good Poor 
5 4 3 2 1 
0.25 0.5 0. 75 1.0 1.25 1.5 5. Lens Movement: 0.25 0.5 O. 75 1.0 1.25 1.5 
1. 75 2.0 2.25 2.5 >2.5 mm (After normal blink in primary gaze) 1. 75 2.0 2.25 2.5 >2.5 mm 
Bearing Aligned Vaulting 6. Lens/Eye Relationship: Bearing Aligned Vaulting 
I 2 3 4 5 6 7 8 9 10 Optic :zone I 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 7. Lens/Eye Relationship: Bearing Aligned Vaulting 
I 2 3 4 5 6 7 8 9 10 Reverse :zone I 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 8. Lens/Eye Relationship: Bearing Aligned Vaulting 
I 2 3 4 5 6 7 8 9 10 Peripheral :zone 1 2 3 4 5 6 7 8 9 10 
1~irnm1r&irnmm::rm:::mmm:m::mmm::~mn:u:mmmtM11rm::1u~s.u.11.ae.1r,mt.A1111simM;:1mrn11:=:@:;:~r.~1m~1m®irnmr1m1wrmm11r:%@:r 
OD OS OD OS OD OS 
1. None D D 5. Dryness/Scratchiness D D 9. Lens Needs Cleaning D D 
2. Discomfort/Awareness D D 6. Variable Vision D D 10. Other D D 
3. Itching/Burning D D 7. Photophobia D D Explain Other: OD: __ _ 
4. Blurred Vision D D 8. Halos D D OS: __ _ 
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
PARAGON VISION 
SCIENCES 
FOLLOW-UP VISIT 1 
TWO WEEK VISIT 
USE BLACK INK ONLY PAGE 1 OF 2 
:w11lm::::::rimmttmmmm1a:mmrirnt?i.:ltlie111;11:1:11n1.u;1mn•111111111r,:m;:mmtrnl:iim11:m::;::i1mm:1m:mmmmm;:;:irn:::1I::: 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
1. Number of days of lens wear since last visit 
2. Average lens wearing time per day since last visit: Hours 
3. Number of hours of lens wear today: Hours 
;M@tM~I:ua1mtt~lw:suUISl~MOITIGU.eEmE.lllD.S8.IHU!Nslll-NB.mff.1@.t~M@rM!Hi 
Questionnaire Complete? (Cirele) YES NO 
OD: Power: Base Curve: OS: Power: 
OD 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
y 
Letters @ 
0.25 0.5 0.75 1.0 
1.75 2.0 2.25 2.5 
Bearing Aligned 
I 2 3 4 5 6 7 
Bearing Aligned 
1 2 3 4 5 6 7 
Bearing Aligned 
1 2 3 4 5 6 7 
1. None 
x 
ft. 
1.25 1.5 
>2.5 mm 
Vaulting 
8 9 10 
Vaulting 
8 9 10 
Vaulting 
8 9 10 
OD OS 
Cl Cl 
2. Discomfort/Awareness Cl Cl 
3. ItchinYBuming Cl Cl 
4. Blurred Vision Cl Cl 
1. Lens Comfort: 
2. SCOR 
3. LogMar High Contrast Acuity 
Single Letter VA with SCOR I test distance 
4. Lens Centration: 
(Jn straight ahead gaz.e, 0.5 mm steps) 
S. Lens Movement: 
(After normal blink in primary gaze) 
6. Lens/Eye Relationship: 
Optic Z.One 
7. Lens/Eye Relationship: 
Reverse Z.One 
8. Lens/Eye Relationship: 
Peripheral Z.One 
OD OS 
5. Dryness/Scratchiness Cl Cl 
6. Variable Vision Cl Cl 
7. Photophobia Cl Cl 
8. Halos Cl Cl 
Base Curve: 
OS 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
Letters @ ft. 
x 
y 
0.25 0.5 0.75 1.0 1.25 1.5 
1.75 2.0 2.25 2.5 >2.5 mm 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
OD OS 
9. Lens Needs Cleaning Cl Cl 
10. Other Cl Cl 
Explain Other: OD: 
OS: 
PARAGON VISION 
SCIENCES 
Investigator No.: 
FOLLOW-UP VISIT 1 
TWO WEEK VISIT 
Date of Visit: 
Subject No.: 
;&1&-11.ae.1iB.:~1•~a.1n1i11~mmiifl}:t.m1mm.r:·:,:::·::'·'::·'JliiliD.DMMHtm~m;@Mmrnm::mmu: 
.... :mrts.111:11t~•1~:U.Bt111.1.111a1111B.r:m.1.riani!IB.ilWr:-··m:mimrnm1m111i@~rmM:m 
OD (circle rade) OS 
2 3 4 1. Edema 0 ..! 1 2 3 4 
2 3 4 2. Neovasculari7.ation -0 1 2 3 4 
2 3 4 3. Stainin 0 1 2 3 4 
2 3 4 4. In· ection 0 1 2 3 4 
2 3 4 5. Tarsal Abnormalities 0 1 2 3 4 
2 3 4 6. Other 0 1 2 3 4 
E lain: 
teaDY abnormal SLE findings: 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distance in feet from atient) 
Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ 
Vertical 4. Keratometry Horimntal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY Attach Tan entlal Plot Power Ma 
6. IOP 
mm./hg mm./hg 
noATOR COMMENTS: 
lQ- Signature: Date: 
r-UP VISIT 
ONTH VIS 
·AGE 1 OF 
Poor 
2 1 
.0 1.25 1.5 
.5 >2.5 mm 
i Vaulting 
7 8 9 IO 
Vaulting 
7 8 9 10 
Vaulting 
7 8 9 10 
Rf.t~W#I1~f.#.~far®I~~::: 
OD OS 
ing Cl Cl 
Cl Cl 
oD: __ _ 
S: __ _ 
CASE REPORT FORM 
STUDY ID: PVS 98 • 2 
PARAGON VISION 
SCIENCES 
FOLLOW-UP VISIT 2 
ONE MONTH VISIT 
.. 
USE BLACK INK ONLY . PAGE 2 OF 2 
M1:m:;,;:::::::::;:gM:;:::1:1::::::;,:::::::::::;:~:;:::::;:;:::::::::::::::::::::::::::M::;::l::~11:~m:11lmmi:::;:rn1U1u.1a1un.111111111:::;,mitf:1::~;r1®;1:@;11::ilirM::t:f~J~::;:m111;@m:M~t:tt1¥~t:~:11w@::1&m:::::: 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
0 1 3 4 ·""" 0 1 3 4 
0 1 2 3 4 2. Neovasclllari7.ation 0 1 2 3 4 
0 1 2 3 4 3. Staini 0 1 2 3 4 
0 1 2 3 4 4. In· ection 0 1 2 3 4 
0 1 2 3 4 5. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
E lain: E lain: 
Describe any abnonnal SLE findings: 
;;mrnm1m~@tt:l®it?Mi¥t.f~B.at1~m~1;~1.Dttmlilll1lillllllt:1.1-~::,::·:v:::·,·~:·:·:;,~:·:::===:,,:·:·: ·,·w1J:w.&zm1mm@1m~1m;&@ 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ 
(Record test distance in feet from atient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ 
Horizontal Vertical 4. Keratometry Horizontal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY Attach Tan ential Plot Power Ma 
6. IOP 
mrn./hg mm./hg 
!il;t!lrili'lll:llfllillllifll• ~~·-•w.m11i:::.·H·O' ...... :: 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
~ 
ft. 
ft. 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
.. 
PARAGON .VISION 
SCIENCES 
FOLLOW-UP VISIT 3 
TWO MONTH VISIT 
USE BLACK INK ONLY. PAGE 1 OF 2 
:::::::m:::::::::::rni::::;::::m;1m~:;:::i::::::::::::::::::::::::::::::::::;:t::1t:;::::::t::m1:ti:::@:::11s.1::1:~;l111P.11mi:E1a111111::::11m:::mrn:i:::::;;:::::l:@:::i::::::lm:::::;:::iMttm11:;;r;m:::::I:l:m: 
Investigator N arne: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
1. Number of days of lens wear since last visit 
2. Average lens wearing time per day since last visit: Hours 
3. Number of hours of lens wear today: / Hours 
1.mm1.m1.mrnrnrn:mv.a11.1.u;!;s.u.m.a.11•111:1.1MRE1.e.am1.11&11G.1.111111atmt.u.m.11rn1.~i~1:::i:::1.~:f:::::m:I::, 
Questionnaire Complete? (Circle) · YES NO 
OD: Power: Base Curve: OS: Power: Base Curve: 
Excellent 
5 
Sphere 
x 
y 
OD 
Good 
4 3 
Cylinder 
Letters @ 
0.25 0.5 0.75 1.0 
1.75 2.0 2.25 . 2.5 
Bearing Aligned 
1 2 3 4 5 6 7 
Bearing Aligned 
1 2 3 4 5 6 7 
Bearing Aligned 
1 2 3 4 5 6 7 
1. None 
2 
x 
Poor 
1 
ft. 
1.25 1.5 
>2.5 mm 
Vaulting 
8 9 10 
Vaulting 
8 9 10 
Vaulting 
8 9 10 
OD OS 
[J [J 
2. Discomfort/ Awareness [J [J 
3. Itching/Burning [J [J 
4. Blurred Vision [J [J 
1. Lens Comfort: 
2. SCOR 
3. LogMar High Contrast Acuity 
Single utter VA with SCOR I test distance 
OS 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
Letters @ ft. 
4. Lens Centration: X 
(Jn straight ahead gaze, 0.5 mm steps) Y 
5. Lens Movement: 
(After normal blink in primary gaze) 
6. Lens/Eye Relationship: 
Dotie Z.One 
7. Lens/Eye Relationship: 
Reverse Z.One 
8. Lens/Eye Relationship: 
Peripheral Z.One 
OD OS 
5. Dryness/Scratchiness [J [J 
6. Variable Vision [J [J 
7. Photophobia [J [J 
8. Halos ·[J [J 
0.25 0.5 0.75 1.0 1.25 1.5 
1.75 2.0 2.25 2.5 >2.5 mm 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
Bearing Aligned · Vaulting 
1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
OD OS 
9. Lens Needs Cleaning [J [J 
10. Other [J [J 
Explain Other: OD: 
OS: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 PARAGON VISION SCIENCES 
FOLLOW-UP VISIT 3 
TWO MONTH VISIT 
USE BLACK INK ONL y · PAGE 2 OF 2 
:::::M;:;;:::::::::::::I1:::::::!::=;:::1111:::::fa:1::;:::::::::;:::::::::::::1=:;::::m:i1:;;1t:iu::1::;:::::i::::;m:::::::::11111m.;;:::1B.111111111:m:::;:;:;:::::1J:i1t:~:::::::::::::::;i::::;::::~;:::::::;:::::;:;::;::::ffi1=::=;:::r;::;1:M:I::;:~11:r1t1l1::ilitmmt:: 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
m:i:::mm11:Im:::rJj@tu:mmmliifilY.1.:111.nflS::1B.1~:a.1B.Y::111:m;nm11m:mm1uuu1•&1::@m::1@:irmmr;;;;:1:11;mm:11111m: 
;,1mritri.Im:mtrnmmm:immmm1r.•11tv;;1swm:;:-a11u.uan.n1itD.mt.1BJ:liifilwn=1:::::@m:1ur;t.fim~:@!im:m~:::m;m 
OD (circle grade)' OS 
0 1 2 3 4 1. Edema ... O 1 2 3 4 
0 1 2 3 4 2. Neovasc'illari7.ation 0 1 2 3 4 
0 I 2 3 4 3. Stainiru! 0 1 2 3 4 
0 1 2 3 4 4. Injection 0 1 2 3 4 
0 1 2 3 4 5. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
Exulain: Explain: 
Describe any abnormal SLE findings: 
@@fm;;::if1::1~~:II~!M1@mi.:::i:!!f.!RD.lt~lf.®&ml.U»llam11.t1NA.UQIUllliiBD.liiil-rniMiJ.@1iff~fJ~1!~Mi.!!¥fH1!j! 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distance in feet from patient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
Horiwntal Vertical 4. Keratometry Horizontal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY (Attach Tangential Plot Power Map) 
6. IOP 
mm./hg mm./hg 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 PARAGON .VISION SCIENCES 
FOLLOW-UP VISIT 4 
THREE MONTH VISIT 
USE BLACK INK ONL 't PAGE 1 OF 2 
:::::::::::;::'::::::'::::::::::i:;::l1:1:E:mi11m:::::;::i:::::;::::::fil:::i::1:::::::::m:::i1m::::::m21111:;::r,::s.um.1111:11111111t111::::::::::m::;:1111:::::::::1::mm::::;MI:m::::::::::1;;!tm1111::M::1::::1m::::::::::::::1 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
1. Number of days of lens wear since last visit 
2. Average lens wearing time per day since last visit: Hours 
3. Number of hours of lens wear today: / Hours 
~~:1~~ra@mrn:::::::I1111t111:s.1ammr1rmr.11Ma11111:aaenam1s.:111-tiili81.~ri1u~m1~~:~r11mr 
Questionnaire Complete? (Circle) . YES NO 
OD: Power: Base Curve: I OS: Power: 
OD 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
y 
Letters @ 
0.25 0.5 0.75 1.0 
1.75 2.0 2.25 2.5 
Bearing Aligned 
1 2 3 4 5 6 7 
Bearing Aligned 
1 2 3 4 5 6 7 
Bearing Aligned 
1 2 3 4 5 6 7 
1. None 
x 
ft. 
1.25 1.5 
>2.5 mm 
Vaulting 
8 9 10 
Vaulting 
8 9 10 
Vaulting 
8 9 10 
OD OS 
[J [J 
2. Discomfort/ Awareness [J [J 
3. Itching/Burning [J [J 
4. Blurred Vision 0 0 
1. Lens Comfort: 
2. SCOR 
3. LogMar High Contrast Acuity 
Single Letter VA with SCOR I test distance 
4. Lens Centration: 
(In straight ahead gu.e, 0.5 mm steps) 
S. Lens Movement: 
(After normal blink in primary gaze) 
6. Lens/Eye Relationship: 
Optic Zone 
7. Lens/Eye Relationship: 
Reverse Zone 
8. Lens/Eye Relationship: 
Peripheral Zone 
OD OS 
5. Dryness/Scratchiness [J [J 
6. Variable Vision [J [J 
7. Photophobia 0 0 
8. Halos 0 0 
Base Curve: 
OS 
Excellent Good Poor 
5 4 3 2 1 
Sphere Cylinder 
x 
Letters @ ft. 
x 
y 
0.25 0.5 0.75 1.0 1.25 1.5 
1.75 2.0 2.25 2.5 >2.5 mm 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 
1 2 3 4 5 6 7 8 9 10 
OD OS 
9. Lens Needs Cleaning [J [J 
10. Other [J [J 
Explain Other: OD: 
OS: 
I 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 PARAGON VISION SCIENCES 
FOLLOW-UP VISIT 4 
THREE MONTH VISIT 
USE BLACK INK ONL y ·· PAGE 2 OF 2 
i:::J;:::f:::::::::::m:::::;mi=:::::::::1:::;,:rn:m:;:::::Iil::::::i:I:I::::::l:=::::m:=:::::::::::l:1.:1ffw:1:1U1a111.;:11W1a111111mM::ii:r~:;::i~::;m:::i:;::;1t.::1;::m11:;,::::r1i::::MmM:::@m:::;:::::i::::i:;~f!!i::::ff;:::::r 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
:rn:rn1n@:1;::;r.nmr.*1@mmia1i.ifilf.l.::Jliiliiltil*-ll•n1.::J1mimiti.ifJ;fiimD1D.ililtiilMI1:11rn1&1w1t:tt.@m:~lt1rn 
:1:1n:i1au1.:@Ii.MMli.i.i.::mm::1~1D.l®li1SllllBtliiD.IMIRIUIR:t,fAJt.lf.-i.il6.f8YIDf:Mf::)t~f:::wriJfj@@J&m@@rn 
OD (circle S?rade)' OS 
0 1 2 3 4 I.Edema 0 1 2 3 4 
2. Neovaseulari7.atio.n 0 1 0 1 2 3 4 2 3 4 
3. Staini112 0 1 0 1 2 3 4 2 3 4 
4. Iniection 0 1 0 1 2 3 4 2 3 4 
5. Tarsal Abnormalities 0 1 0 1 2 3 4 2 3 4 
6. Other 0 1 0 1 2 3 4 2 3 4 
Exolain: Exolain: 
Describe any abnormal SLE findings: 
~m:::rn:~mam:::M%1l~!M!MlM¥ltllllf.Wtf.iltlQml~lllMilll1Hllllli.i~-~~~:·:·:·:·:·:::::::·::''::::·:·::7;11m@falff{~fffftt4i.@Mf~!~~;;:: 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distance in feet from patient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
4. Keratometry Horizontal Vertical 
@ @ 
Horizontal Vertical 
5. CORNEAL TOPOGRAPHY (Attach Tangential Plot Power Map) 
6. IOP 
mm./hg mm./hg 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
,. 
PARAGON VISION 
SCIENCES 
D Unscheduled Visit 
D Discontinuation Visit 
USE BLACK INK ONLY PAGE 1 OF 2 
:::i:~;:~~11t:t,~:::::rn::::mm:::::::::w::::::::@::::;;;:::::::®:::::;:::::;,;::::::::::::;s1::::::::::rn:rn::n1111111;::1;:1111e.11~1111.1na1:;;:1:::&::::::&::::::::;:m1::11::i:;m1m:mJ1:::::111~1~W:~1J1:1:m1:&1:;:::1:1f:: 
Investigator N arne: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
1. Number of days of lens wear since last visit 
2. Average lens wearing time per day since last visit: Hours 
3. Number of hours of lens wear today: Hours 
mMm::im1;:m%w:11r£1.u1~:ts.u.11.m1J111s.11111rte.smt.11.u.sm1tius.11::1.8.1SSD.11.a.11t.11rn~~mi1mm::::::::m 
Questionnaire Complete? (Cirtle) YES NO 
OD: Power: Base Curve: I OS: Power: Base Curve: 
OD OS 
Excellent Good Poor 1. Lens Comfort: Excellent Good Poor 
5 4 3 2 1 5 4 3 2 1 
2. SCOR 
Sphere Cylinder Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with SCOR I test distanc.e Letters @ ft. 
x 4. Lens Centration: x 
y (In straight ahead gaze, 0.5 mm steps) y 
0.25 0.5 0.75 1.0 1.25 1.5 S. Lens Movement: 0.25 0.5 0.75 1.0 1.25 1.5 
1.75 2.0 2.25 2.5 >2.5 mm (After normal blink in primary gaze) 1.75 2.0 2.25 2.5 >2.5 mm 
Bearing Aligned Vaulting 1 6. Lens/Eye Relationship: Bearing Aligned Vaulting l 
2 3 4 5 6 7 8 9 10 Ootic Zone 1 2 3 4 5 6 7 8 9 10 
Bearing Aligned Vaulting 1 7. Lens/Eye Relationship: Bearing Aligned Vaulting 
2 3 4 5 6 7 8 9 10 Reverse Zone 1 2 3 4 5 6 7 8 9 10 I 
' 
Bearing Aligned Vaulting 1 8. Lens/Eye Relationship: Bearing Aligned Vaulting I 
2 3 4 5 6 7 8 9 10 Perinheral Zone 1 2 3 4 5 6 7 8 9 10 
OD OS OD OS OD OS 
1. None Cl Cl 5. Dryness/Scratchiness Cl Cl 9. Lens Needs Cleaning Cl Cl 
2. Discomfort/ Awareness Cl Cl 6. Variable Vision Cl Cl 10. Other Cl Cl 
3. ItchinW'Buming Cl Cl 7. Photophobia Cl Cl Explain Other: OD: 
4. Blurred Vision Cl Cl 8. Halos Cl Cl OS: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 PARAGON VISION SCIENCES 
D Unscheduled Visit 
D Discontinuation Visit 
USE BLACK INK ONLY .. PAGE20F2 
Investigator N arne: Investigator No. : Date of Visit: 
Subject N rune: Subject No.: 
::mrn::m::::i::rn1:=:11:Iim~mmm1.11.11ili11;ms.umam11n;BMiu.DD.1ru.at.1DSilimlllFmIHlmii&},f#:~mmm~1:mim::::1 
OD (circle OS 
0 1 2 3 4 1. Edema 0 1 2 3 4 
0 1 2 3 4 2. Neovascularii.ation 0 1 2 3 4 
0 1 2 3 4 3. Staini .l 0 1 2 3 4 
0 1 2 3 4 4. In· ection 0 1 2 3 4 
0 1 2 3 4 5. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
E lain: E lain: 
Describe any abnormal SLE findings: 
:nt@JiHi.i&IIIle~ll~MICUEltl:SllllNi.TRl&I'';Wi.tioltitil.J.ii:[lfJ-i.lil.if§iB.i.md.Wl:'•t~Iit.irmm:;mmt 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distance in feet from atient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
Hori:zontal Vertical 4. Keratometry Horiz.ontal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY Attach Tan entlal Plot Power Ma 
6. IOP 
mm./ hg mm. I hg 
:aWf.iMtii@i.milMAB.mB.t:llt.MRDSDN!:B.ll!llSiltH~IJ-~9.lllf':: ..  ::~:'~ .. ''''.'.'.::=~.·:~aiif'7ifii. ''llitf.f~iiaf:1.~ll~W:m;1: 
Q Unacceptable Visual Acuity 1:1 Protocol Violation 
Q Lack of Comfort 1:1 Missed Visits 
Q Lack of Interest 1:1 Pathology/ Adverse Reaction (Complete Adverse Reaction Form) 
Q Lost to Follow-Up 1:1 Other:-----------------
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
PARAGON .VISION 
SCIENCES FOLLOW-UP VISIT 5 8 HOURS POST 3 MONTH 
USE BLACK INK ONL y ·· PAGE 1 OF 2 
ii!ii!!i!lii!!!!!!ii!)i!ii.!fili!!i!!i!i!::;::::mM:::;tMi!ii!!!iii!:::::::~:@Mt:m:i:I:I:::;:::::::;:;1111r,1;:::!i'!Blllllii.ll&IB.MIW.ll:fjif:i!Mifil'!iMrnMMiii!liil!l!lil!@i~M:::i!lH!:~f1IMi!limrli.!i::;;::: 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distam:e in feet from atient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
Horizontal Vertical 4. Keratometry Horizontal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY Attach Tan ential Plot Power Ma 
OD (circle rade) OS 
0 1 2 3 4 1. Edema 0 1 2 3 4 
0 1 2 3 4 2. Neovasculari7.3tion 0 1 2 3 4 
0 1 2 3 4 3. Stainin 0 1 2 3 4 
0 1 2 3 4 4. In· ection 0 1 2 3 4 
0 1 2 3 4 S. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
E lain: E lain: 
~cribe any abnonnal SLE findings: 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 • 2 
PARAGON VISION 
SCIENCES 
FOLLOW-UP VISIT 6 
24 HOURS POST 3 MONTH 
•' 
USE BLACK INK ONLY . PAGE 1 OF 2 
fallIEilittittt~;;:tium:m:::t&iI:iil!HI@ltH:::11BltJ.~@IUll.E.G.ll:~ilHtORMIDD:llifilftM!i~f:i:@;1:1;rn:rnm~@~j[f@JJ.Ifrl~Efr@l@m: 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
mrnwMt::m1t1t1111mt.:.is.1mmtr111J.n~::eue-e.u.11mn.¥e.ast.au.1111111111e.1Mrnmmimrn 
Questionnaire Complete? (Circle) YES NO 
OD OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distance in feet from patient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
·X x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
Horizontal Vertical 4. Keratometry H<rimntal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY (Attach Tangential Plot Power Map) 
OD (circle grade) OS 
0 1 2 3 4 1. Edema 0 1 2 3 4 
0 1 2 3 4 2. Neovasculari.7.ation 0 1 2 3 4 
0 1 2 3 4 3. Stainiru! 0 1 2 3 4 
0 1 2 3 4 4. lniection 0 1 2 3 4 
0 1 2 3 4 S. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
Exolain: Exolain: 
Describe any abnormal SLE findings: 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
PARAGON .VISION 
SCIENCES FOLLOW-UP VISIT 7 48 HOURS POST 3 MONTH 
USE BLACK INK ONL V PAGE 1 OF 2 
:irnl:::::::::::::::[j;:::::m::1:;:::::;::1:;:i;m:::::l:i@ll!:::::::::::::@1:1:1::::::=:::::i:l:::::::::::::~:e1BJ.t:lf:l!!i!$.llU:lllJ,iJN&llMIW.ifl.t~l~ii!W!::::::;~~jlltri1iM!i!ii!!1l?i!:jrniM!Jf~~jf:ff,i]Ml;i@i!:I:t;::: 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
t.titMJ.fMMifJjj::::eAlQtUlt.istJf.llEIJ.t.il.l$.lfillm-•1&1.tt1\tlell.J.lll-Rll1ll$3.l.f.f.ri.f.Jill@¥ 
Questionnaire Complete? (Circle) YES NO 
:w.1mmir.mM;~~;m11 11111u.:r~nu.•1uu.m-1 11--1~••re&nw1¥mt1.1s.•~r@f:m::;:f;wf:t1~1m;w 
OD , OS 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Letter VA Unaided Letters @ ft. 
(Record test distance in feet from patient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
.x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
Hcrimntal Vertical 4. Keratometry Hcrimntal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY (Attach Tangential Plot Power Map) 
OD (circle mule) OS 
0 1 2 3 4 1. Edema 0 1 2 3 4 
0 1 2 3 4 2. Neovascularization 0 1 2 3 4 
0 1 2 3 4 3. Staini112 0 1 2 3 4 
0 1 2 3 4 4. In.iection 0 1 2 3 4 
0 1 2 3 4 S. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
Exnlain: Exnlain: 
Describe any abnormal SLE findings: 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
CASE REPORT FORM 
STUDY ID: PVS 98 - 2 
PAKAGUN VISION 
SCIENCES FOLLOW-UP VISIT 8 72 HOURS POST 3 MONTH 
USE BLACK INK ONL y · PAGE 1 OF 2 
IIt1::mmi::::::1nttMm:It!:::::rn:IIm:11i:~m::m;::rn::::::i@tRIBWiJ.~ms.ua1.ammiNEIBMID.ll:i:;:m1m~:~f,!:::;:~g;;::ifMii:i!i@i.llMlf&~W@iMmm¥IIi@f 
Investigator Name: Investigator No.: Date of Visit: 
Subject Name: Subject No.: 
M1fl@~mm:~fitllB.ltllif.11810.11111mtt.!l.ill&fltiD.IB.llm~S.i.Rl~QUISl(QRlliB.S.@i;M~~{.t;fi~11llili 
Questionnaire Complete? (Circle) YES NO 
1. Unaided LogMar High Contrast 
Letters @ ft. Acuity Single Lener VA Unaided Letters @ ft. 
(Record test distance in feet from patient) 
Sphere Cylinder 2. Subjective Refraction Sphere Cylinder 
.x x 
3. LogMar High Contrast Acuity 
Letters @ ft. Single Letter VA with Subjective Refraction Letters @ ft. 
Horizontal Vertical 4. Keratometry H<rizontal Vertical 
@ @ 
5. CORNEAL TOPOGRAPHY (Attach Tangential Plot Power Map) 
OD (circle grade) OS 
0 1 2 3 4 1. Edema 0 1 2 3 4 
0 1 2 3 4 2. Neovasculari7.3tion 0 1 2 3 4 
0 1 2 3 4 3. Stainin2 0 1 2 3 4 
0 1 2 3 4 4. In,iection 0 1 2 3 4 
0 1 2 3 4 S. Tarsal Abnormalities 0 1 2 3 4 
0 1 2 3 4 6. Other 0 1 2 3 4 
Exnlain: Explain: 
Describe any abnormal SLE findings: 
INVESTIGATOR COMMENTS: 
Investigator Signature: Date: 
Questionnaire to be administered at the BASELINE Visit prior to removing the subjects 
habitually worn correction. The patient must be wearing the correction while filling out the 
questionnaire. 
·· Patient Questionnaire - Habitual Correction 
.. · 
Patient Name Date 
1. A. What, if anything, do you like about your current correction for your vision? 
/ 
I 
B. What, if anything, do you dislike about y~:lUf current correction for your vision? 
2. On average, how many days a week do you wear your correction for your vision? 
3. On average, how many hours a day do you wear your correction for your vision? 
4. Please rate the current correction for your vision on the following visual attributes. 
Check only one box per line. 
Overall visual sharpness and clarity 
Night Vision/low or dim light situations 
(such as driving at night or reading a 
menu in a dark restaurant) 
Consistent vision throughout the day 
(Stable or variable vision while 
wearing your correction?) 
Vision while participating in sport activities 
(if applicable) 
Which sport(s)? _______ _ 
Vision while working (such as working at a 
computer, reading fine print, long periods 
of close work) 
Excellent Poor 
10 9 8 7 6 5 4 3 2 1 
0000000000 
10 9 8 7 6 5 4 3 2 1 
0000000000 
10 9 8 7 6 5 4 3 2 1 
0000000000 
10 9 8 7 6 5 4 3 2 1 
0000000000 
10 9 8 7 6 5 4 3 2 1 
0000000000 
5. Please rate your unaided vision on the following visual attributes. 
Check only one box per line. 
... · 
Overall visual sharpness and clarity 
Night Vision/low or dim light situations 
(such as driving at night or reading a 
menu in a dark restaurant) 
Consistent vision throughout the day 
(Stable or variable unaided vision) 
Vision while participating in sport activities 
(if applicable) 
Which sport(s)? _______ _ 
Vision while working (such as working at a 
computer, reading fine print, long periods 
of close work) 
Excellent Poor 
7 6 5 4 3 2 1 
(J (J (J (J (J (J 0 
7 6 5 4 3 2 1 
0 0 (J (J (J (J (J 
10 9 8 
(J (J (J 
10 9 8 
(J (J (J 
10 9 8 7 6 5 4 3 2 1 
/t:lOOOOOOOOO 
..... 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J 0 0 
6. Overall, how satisfied are you with the correction for your vision you currently wear? 
Very 
Satisfied 
10 9 8 7 
(J (J (J (J 
Not At All 
Satisfied 
6 5 4 3 2 1 
(J (J (J (J (J 0 
7. Overall, how satisfied are you with your unaided vision? 
Very 
Satisfied 
10 9 8 7 6 5 
(J (J (J (J (J (J 
Not At All 
Satisfied 
4 3 2 1 
(J (J (J (J 
Questionnaire to be administered at the Follow-Up Visit before removing the clinical study 
lenses. The patient must be wearing the study lenses while filling out the questionnaire. 
Patient Questionnaire - Study Lenses: Two Week 
Patient Name .. · Date 
1. A. What, if anything, do you like about this pair of study lenses? 
/ 
I 
8. What, if anything, do you dislike about t~isi:>air of study lenses? 
2. On average, how many days a week did you wear your study lenses? ___ _ 
3. On average, how many hours a day did you wear your study lenses? 
4. Please rate the study contact lenses on the following visual attributes. 
Check only one box per line. 
Overall visual sharpness and clarity 
Night Vision/low or dim light situations 
(such as driving at night or reading a 
menu in a dark restaurant) 
Consistent vision throughout the day 
(Stable or variable vision with 
the study lenses) 
Vision while participating in sport activities 
(if applicable) 
Which sport(s)? _______ _ 
Vision while working (such as working at a 
computer, reading fine print, long periods 
of close work) 
Excellent Poor 
10 9 8 7 6 5 4 3 2 1 
Cl Cl Cl CJ Cl CJ CJ Cl Cl CJ 
10 9 8 7 6 5 4 3 2 1 
Cl CJ Cl CJ CJ Cl CJ Cl CJ CJ 
10 9 8 7 6 5 4 3 2 1 
(J(J(JCJ[J[J[J(J(J(J 
10 9 8 7 6 5 4 3 2 1 
Cl CJ CJ CJ CJ CJ CJ Cl Cl CJ 
10 9 8 7 6 5 4 3 2 1 
(J(JCJCJCJ(JCJCJCJ(J 
5. Please rate the contact lenses used during the study on the following comfort attributes. 
Check only one box per line . 
... · Excellent Poor 
10 9 8 7 6 5 4 3 2 1 
Comfort of the lenses when you first put them in O O O O O O O 0 0 0 
10 9 8 7 6 5 4 3 2 1 
Comfort of the lenses at the end of the wear O O O O O O 0 0 0 0 
10 9 8 7 6 5 4 3 2 1 
Overall comfort O O O O O . Cl Cl 0 Cl 0 
6. Please rate your unaided vision on the followinQ-·visual attributes . 
Check only one box per line. 
Overall visual sharpness and clarity 
Night Vision/low.or dim light situations 
(such as driving at night or reading a 
menu in a dark restaurant) 
Consistent vision throughout the day 
(Stable or variable unaided vision) 
Vision while participating in sport activities 
(if applicable) 
Which sport(s)? _______ _ 
Vision while working (such as working at a 
computer, reading fine print, long periods 
of close work) 
.. -
Excellent Poor 
7 6 5 4 3 2 1 
0000000 
7 6 5 4 3 2 1 
10 9 8 
0 0 0 
10 9 8 
0 0 0 0 0 0 Cl 0 Cl Cl 
10 9 8 7 6 5 4 3 2 1 
0000000000 
10 9 8 7 6 5 4 3 2 1 
0 0 0 0 Cl Cl Cl Cl 0 Cl 
10 9 8 7 6 5 4 3 2 1 
Cl 0 0 0 Cl Cl 0 Cl 0 Cl 
7. Overall, how satisfied are you with the correction for your vision with the study lenses? 
Very 
Satisfied 
10 9 8 7 6 5 
0 0 0 0 0 0 
Not At All 
Satisfied 
4 3 2 1 
0 0 0 0 
8. Overall, how satisfied are you with your unaided vision? 
Very 
Satisfied 
10 9 8 7 6 5 4 3 
0 0 Cl 0 Cl 0 0 0 
Not At All 
Satisfied 
2 1 
0 Cl 
Questionnaire to be administered at the Follow-Up Visit before removing the clinical study 
lenses. The patient must be wearing the lenses while filling out the questionnaire. 
Patient Questionnaire - Study Lenses: One Month 
Patient Name .. · Date 
1. A. What, if anything, do you like about this pair of study lenses? 
. 
I 
I 
B. What, if anything, do you dislike about t~is ... pair of study lenses? 
2. On average, how many days a week did you wear your study lenses? ___ _ 
3. On average, how many hours a day did you wear your study lenses? 
4. Please rate the study contact lenses on the following visual attributes. 
Check only one box per line. 
Overall visual sharpness and clarity 
Night Vision/low or dim light situations 
(such as driving at night or reading a 
menu in a dark restaurant) 
Consistent vision throughout the day 
(Stable or variable vision 
with the study lenses) 
Vision while participating in sport activities 
(if applicable) 
Which sport(s)? _______ _ 
Vision while working (such as working at a 
computer, reading fine print, long periods 
of close work) 
Excellent Poor 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
IJ IJ IJ IJ IJ IJ IJ IJ IJ a 
5. Please rate the contact lenses used during the study on the following comfort attributes. 
Check only one box per llne. 
Excellent 
10 9 8 7 6 5 4 
Comfort of the lenses when you first put them in (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 
Poor 
3 2 1 
(J (J (J 
3 2 1 
(J (J (J Comfort of the lenses at the end of the wear (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J Overall comfort (J (J (J (J (J !J !J 
6. Please rate your unaided vision on the following visual attributes . . 
Check only one box per line. 
Overall visual sharpness and clarity 
Night Vision/low or dim light situations 
(such as driving .at night or reading a 
menu in a dark restaurant) 
Consistent vision throughout the day 
(Stable or variable unaided vision) 
Vision while participating in sport activities 
(if applicable) 
Which sport(s)? _______ _ 
Vision while working (such as working at a 
computer, reading fine print, long periods 
of close work) 
. 
I 
I 
Excellent · Poor 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
10 9 8 7 6 5 4 3 2 1 
(J (J (J (J (J (J (J (J (J (J 
7. Overall, how satisfied are you with the correction for your vision with the study lenses? 
Very 
Satisfied 
10 9 8 7 6 5 
(J (J (J (J (J (J 
Not At All 
Satisfied 
4 3 2 1 
(J (J (J (J 
8. Overall, how satisfied are you with your unaided vision? 
Very 
Satisfied 
10 9 8 7 6 5 
(J (J (J (J (J (J 
Not At All 
Satisfied 
4 3 2 1 
(J (J (J (J 
